Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Acquisition
Biotech
AbbVie acquires oral peptide biotech Nimble for $200M
AbbVie is paying $200 million to acquire Nimble Therapeutics and its lead asset, a preclinical oral peptide being evaluated as a psoriasis treatment.
Gabrielle Masson
Dec 13, 2024 10:38am
Health tech firm scoops up patient-matching AI company Realyze
Dec 9, 2024 5:25pm
American Clinical bumps up site count with Elixia acquisition
May 8, 2024 2:44pm
Eliem cuts in on Tango, proposing acquisition after review
Mar 19, 2024 10:57am
Headlands acquires Pharmasite to expand mental health trials
Feb 29, 2024 4:20pm
Another company bid against BMS' $14B offer for Karuna
Jan 22, 2024 4:39pm
